Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Tenchusatsu who wrote (1410328)	7/14/2023 2:11:49 PM
From: golfer72	Read Replies (1) \| Respond to of 1574115

There is all kinds of empirical evidence on HCQ and Ivermectin and their effectiveness. Stop lying. I exposed you yesterday for being a liar and here you go again. Quit while you are behind

To: Tenchusatsu who wrote (1410328)	7/14/2023 2:16:52 PM
From: golfer72	Respond to of 1574115

From Virology Journal 2005 ( Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Martin J Vincent1, Eric Bergeron2, Suzanne Benjannet2, Bobbie R Erickson1, Pierre E Rollin1, Thomas G Ksiazek1, Nabil G Seidah2 and Stuart T Nichol1 ) (its a PDF so cant attach it)*

To: Tenchusatsu who wrote (1410328)	7/14/2023 2:25:10 PM
From: golfer72	1 Recommendation Recommended By bjzimmy Respond to of 1574115

HCQ for COVID-19 402 studies from 8,467 scientists 522,536 patients in 58 countries Statistically significant improvement for mortality, hospitalization, recovery, cases, and viral clearance. 62%, 20% improvement for early and late treatment CI [53-70%], [16-25%]; 37, 261 studies 23% improvement in 8 early treatment RCTs CI [-20-51%] 72% less death in 16 early treatment trials CI [59-81%] (c19hcq.org)